U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Asthma Medication Use Among Adults with Current Asthma by Work-Related Asthma Status, Asthma Call-Back Survey, 29 States, 2012–2013

Public Domain


Details

  • Personal Author:
  • Description:
    Objective: Asthma severity is defined as the intensity of treatment required to achieve good control of asthma symptoms. Studies have shown that work-related asthma (WRA) can be associated with poorer asthma control and more severe symptoms than non-WRA. Associations between asthma medications and WRA status were assessed using data from the 2012-2013 Asthma Call-back Survey among ever-employed adults (>/=18 years) with current asthma from 29 states. Methods: Persons with WRA had been told by a physician that their asthma was work-related. Persons with possible WRA had asthma caused or made worse by their current or previous job, but did not have physician-diagnosed WRA. Asthma medications were classified as controller (i.e., long-acting beta-agonist, inhaled corticosteroid, oral corticosteroid, cromolyn/nedocromil, leukotriene pathway inhibitor, methylxanthine, anticholinergics) and rescue (i.e., short-acting â-agonist). Demographic and clinical characteristics were examined. Associations between asthma medications and WRA status were assessed using a multivariate logistic regression to calculate adjusted prevalence ratios (PRs). Results: Among an estimated 15 million ever-employed adults with current asthma, 14.7% had WRA and an additional 40.4% had possible WRA. Compared with adults with non-WRA, those with WRA were more likely to have taken anti-cholinergics (PR=1.80), leukotriene pathway inhibitor (PR=1.59), and methylxanthine (PR=4.76), and those with possible WRA were more likely to have taken methylxanthine (PR = 2.85). Conclusions: Results provide additional evidence of a higher proportion of severe asthma among adults with WRA compared to non-WRA. To achieve optimal asthma control, adults with WRA may require additional intervention, such as environmental controls or removal from the workplace exposure. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0277-0903
  • Document Type:
    Text
  • Genre:
    Journal Article
  • Place as Subject:
  • CIO:
    National Institute for Occupational Safety and Health (NIOSH)
  • Division:
    RHD - Respiratory Health Division
  • Topic:
    Workplace Safety & Health
  • Location:
    North America
  • Pages in Document:
    364-372
  • Volume:
    55
  • Issue:
    4
  • NIOSHTIC Number:
    nn:20050569
  • Citation:
    J Asthma 2018 Apr; 55(4):364-372
  • Contact Point Address:
    Katelynn E Dodd, Respiratory Health Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS HG900, Morgantown,WV 26505
  • Federal Fiscal Year:
    2018
  • Peer Reviewed:
    True
  • Source Full Name:
    Journal of Asthma
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:545d4a41593f047a5504f77aa3798c5307a2d17d0cfdc337e782eea7ecaf01a201de9da3bdeacf61f56627eb6ec514051d87cebac59393945dc7ba9cb04b6849
  • Download URL:
  • File Type:
    Filetype[PDF - 742.47 KB ]
PREVIOUS
ON THIS PAGE
Details
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP